Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Evaxion Biotech (EVAX)
NASDAQ:EVAX
Holding EVAX?
Track your performance easily
EVAX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.28 - $13.61
Previous Close$1.51
Volume19.05K
Average Volume (3M)53.48K
Market Cap
$8.01M
Enterprise Value$13.46M
Total Cash (Recent Filing)$5.58M
Total Debt (Recent Filing)$10.87M
Price to Earnings (P/E)―
Beta1.11
Next Earnings
Apr 08, 2025EPS Estimate
-$0.42Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.91
Shares Outstanding5,580,000
10 Day Avg. Volume66,053
30 Day Avg. Volume53,482
Standard Deviation0.22
R-Squared0.00243
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)-1.65
Price to Sales (P/S)119.24
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit184.35
Enterprise Value/Ebitda-1.33
Forecast
1Y Price Target
$10.50Price Target Upside609.46% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Evaxion Biotech News
PremiumCompany Announcements
Evaxion Biotech Appeals Nasdaq Delisting Decision
PremiumCompany Announcements
Evaxion Biotech Plans Strategic Capital Increase
PremiumCompany Announcements
Evaxion Biotech Advances CMV Vaccine with AI Innovation
PremiumCompany Announcements
Evaxion Biotech Reports Q3 Progress and FinancialsOwnership Overview
―
Insiders
0.06% Mutual Funds
9.70% Other Institutional Investors
90.24% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
EVAX FAQ
What was Evaxion Biotech’s price range in the past 12 months?
Evaxion Biotech lowest stock price was $1.28 and its highest was $13.61 in the past 12 months.
What is Evaxion Biotech’s market cap?
Currently, no data Available
When is Evaxion Biotech’s upcoming earnings report date?
Evaxion Biotech’s upcoming earnings report date is Apr 08, 2025 which is in 132 days.
How were Evaxion Biotech’s earnings last quarter?
Evaxion Biotech released its earnings results on Oct 31, 2024. The company reported -$0.04 earnings per share for the quarter, beating the consensus estimate of -$0.313 by $0.273.
Is Evaxion Biotech overvalued?
According to Wall Street analysts Evaxion Biotech’s price is currently Undervalued.
Does Evaxion Biotech pay dividends?
Evaxion Biotech does not currently pay dividends.
What is Evaxion Biotech’s EPS estimate?
Evaxion Biotech’s EPS estimate is -$0.42.
How many shares outstanding does Evaxion Biotech have?
Evaxion Biotech has 5,576,055 shares outstanding.
What happened to Evaxion Biotech’s price movement after its last earnings report?
Evaxion Biotech reported an EPS of -$0.04 in its last earnings report, beating expectations of -$0.313. Following the earnings report the stock price went down -3.261%.
Which hedge fund is a major shareholder of Evaxion Biotech?
Among the largest hedge funds holding Evaxion Biotech’s share is Invst, LLC. It holds Evaxion Biotech’s shares valued at 134K.
---
Evaxion Biotech Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.50 (609.46% Upside)
$10.50 (609.46% Upside)
Blogger Sentiment
Neutral
EVAX Sentiment 50%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 10.8K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-82.43%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
27.16%
Trailing 12-Months
Company Description
Evaxion Biotech
Evaxion Biotech AS is an artificial intelligence immunology platform company. It uses proprietary AI technology, engineering expertise and drug development know-how to simulate the human immune system and generate predictive models to identify and develop efficacious immunotherapies for patients in the global market.
---
EVAX Earnings Call
Q3 2024
0:00 / 0:00
---
EVAX Stock 12 Month Forecast
Average Price Target
$10.50
▲(609.46% Upside)
Technical Analysis
Best Analysts Covering EVAX
1 Year
1 Year Success Rate
0/7 ratings generated profit
1 Year Average Return
-53.16%
reiterated a buy rating 26 days ago
Copying Swayampakula Ramakanth's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -53.16% per trade.
---